Clostridioides difficile (C. diff) is a bacterium that infects the gut and causes symptoms ranging from mild diarrhoea to severe inflammation of the colon. It usually develops after antibiotic use, which disrupts the balance of healthy gut bacteria and allows C. difficile to grow.
Content outline
- What is Clostridioides difficile?
- What causes C. difficile infection?
-
Why is C. difficile controversial?
- 1. It can exist without causing symptoms
- 2. Colonisation vs infection is difficult to distinguish
- 3. Testing methods can be misleading
- 4. The gut microbiome plays a central role
- 5. Not all strains are equally harmful
- 6. High recurrence rates challenge traditional treatment
- 7. Evolving treatment approaches reflect the debate
- 8. Overdiagnosis and overtreatment concerns
- How is C. difficile treated?
- How to reduce the risk of C. difficile infection
- Summary
What is Clostridioides difficile?
Clostridioides difficile, formerly known as Clostridium difficile, commonly known as C. diff, is a bacterium that can cause severe diarrhea and other intestinal problems [1]. The bacterium can be found in the gut of healthy individuals, but when the balance of the gut microbiome is disrupted, C. diff can overgrow and cause disease.
C. difficile is considered a harmful or bad bacterium because it produces toxins that can cause severe diarrhea and inflammation of the colon. The toxins, known as toxins A and B, damage the cells lining the colon, leading to inflammation and fluid accumulation in the colon. This results in diarrhea, abdominal pain, fever, and in severe cases, colitis or pseudomembranous colitis, which can be life-threatening.
C. difficile infections typically occur in individuals who have recently taken antibiotics [2], which can disrupt the normal balance of bacteria in the gut and create an environment favorable to C. difficile growth. The elderly, hospitalized patients, and those with weakened immune systems are at higher risk for C. difficile infections [3].
Symptoms of C. difficile infection
Symptoms can range from mild to severe, depending on the extent of gut microbiome disruption.
Common symptoms include:
- Diarrhea (often watery and frequent)
- Abdominal pain and cramping
- Nausea and vomiting
- Fever
- Loss of appetite
- Dehydration [4]
In severe cases, C. difficile infection can lead to colitis or pseudomembranous colitis, which can cause complications such as:
- Severe dehydration
- Rapid heart rate
- Bowel perforation
- Toxic megacolon (severe colon inflammation)
- Septicemia (blood infection)
- Kidney failure
- Death
Prompt diagnosis and treatment are essential to prevent complications and reduce the risk of transmission to others.
What causes C. difficile infection?
C. difficile is caused by an imbalance in gut bacteria, most often triggered by antibiotics.
Main causes:
- Antibiotic use
- Hospital or healthcare exposure
- Weakened immune system
- Older age (65+)
- Previous infection [5]
Antibiotics have been found to be a significant risk factor for C. diff infection. Antibiotics can disrupt the natural balance of the gut microbiome, leading to the overgrowth of C. diff. This overgrowth can cause diarrhea, inflammation, and other intestinal problems. Studies have shown that individuals who receive antibiotics are 7 to 10 times more likely to develop C. diff infections [6], and the risk is even higher for those who receive broad-spectrum antibiotics or multiple courses of antibiotics.
Why is C. difficile controversial?
C. difficile is considered controversial because its presence in the gut does not always mean it is causing disease [7]. This makes diagnosis, treatment, and interpretation of test results more complex than with many other infections.
1. It can exist without causing symptoms
Unlike many pathogens, C. difficile can live in the gut without causing any harm [8].
- Some healthy individuals carry the bacteria with no symptoms
- Colonisation is especially common in infants and hospitalised patients
- Not all carriers will develop an infection
This raises an important question: when is C. difficile actually a problem?
2. Colonisation vs infection is difficult to distinguish
One of the biggest challenges is telling the difference between:
- Colonisation: bacteria present but harmless
- Infection: bacteria actively producing toxins and causing symptoms
Modern tests are highly sensitive and can detect C. difficile DNA even when toxins are not being produced [9]. This means:
- Positive test results do not always indicate active disease
- Some patients may be diagnosed and treated unnecessarily
3. Testing methods can be misleading
Different diagnostic approaches can give different results:
- PCR tests detect bacterial genes but not toxin activity
- Toxin assays detect active toxin production but may miss cases
Because of this, clinical guidelines often recommend combining tests with symptom assessment. However, variability in testing approaches continues to fuel debate.
4. The gut microbiome plays a central role
C. difficile infection is not just about the presence of the bacteria—it’s about the state of the gut microbiome [10].
- A healthy microbiome can suppress C. difficile growth
- Antibiotics can disrupt this balance, allowing overgrowth
- Recovery depends on restoring microbial diversity
This has shifted thinking from a purely “pathogen-focused” model to a microbiome-centred view of disease.
5. Not all strains are equally harmful
There are multiple strains of C. difficile, and they vary in their ability to produce toxins [11].
- Some strains produce little or no toxin
- Others are highly virulent and linked to severe outbreaks
This variability makes it harder to predict outcomes based on detection alone.
6. High recurrence rates challenge traditional treatment
C. difficile often returns after treatment:
- Around 1 in 4 people experience recurrence after the first infection within 4 weeks [12]
- Risk increases with each subsequent episode
This suggests that:
- Eliminating the bacteria is not always enough
- Long-term recovery depends on restoring the gut ecosystem
7. Evolving treatment approaches reflect the debate
Traditional treatment focuses on antibiotics, but newer approaches highlight the importance of the microbiome:
- Faecal microbiota transplantation (FMT)
- Microbiome-targeted therapies
- Prebiotics and probiotics
These approaches challenge the idea that infections should only be treated by killing bacteria.
8. Overdiagnosis and overtreatment concerns
Because C. difficile can be present without causing disease:
- Some patients may be treated unnecessarily
- Antibiotic treatment can further disrupt the microbiome
- This may increase the risk of recurrence
As a result, clinicians are increasingly cautious about when to treat.
How is C. difficile treated?
While antibiotics, such as vancomycin, are often used to treat C. diff infections [13], there has been concern about the development of antibiotic-resistant strains of C. diff. Antibiotic use can further disrupt the gut microbiome, which can prolong C. diff infections or lead to recurrence. As a result, there has been growing interest in using FMT as an alternative treatment for C. diff infections.
Fecal microbiota transplantation (FMT): FMT involves the transfer of fecal material from a healthy donor into the gut of a patient with C. diff infection [14]. The goal of FMT is to restore the balance of the gut microbiome and eliminate the overgrowth of C. diff. While FMT has been found to be the most effective method for treating C. diff infections [15], there has been controversy surrounding its use.
One concern about FMT is the potential risk of transmitting infectious diseases from the donor to the recipient. Donors must be carefully screened for infectious diseases, and the fecal material must be prepared and administered under strict conditions to minimize the risk of infection. Despite these precautions, there have been reports of infections and adverse events associated with FMT.
Another concern about FMT is the lack of standardized protocols for preparation and administration. There is currently no consensus on the optimal method for preparing and administering fecal material, which can lead to variability in effectiveness and safety. Additionally, FMT is not widely available and can be expensive, which can limit its use as a treatment option.
While there is controversy surrounding the use of FMT for C. diff infections, there is growing interest in FMT's potential for other conditions thought to be related to the gut microbiome, such as inflammatory bowel disease and metabolic disorders. As research in this area continues, the controversy surrounding FMT is likely to persist.
Can prebiotics help?
-
2′‑FL and LNnT inhibit C. difficile in vitro (Vigsnaes et al., 2021)
This paper used two lab models—including the Pathogut™ and SHIME® systems—to demonstrate that 2′‑fucosyllactose (2′‑FL), lacto‑N‑neotetraose (LNnT), and their 4:1 combination significantly reduced C. difficile levels across multiple human donor microbiomes. The mechanism appeared to be indirect—via enhanced growth of beneficial Bifidobacteriaceae, increased short‑chain fatty acids and secondary bile acids—rather than a direct antimicrobial effect [16]. - 2′‑FL suppresses C. difficile outgrowth in a complex human community (Frontiers in Cellular and Infection Microbiology, 2022)
Using the CDi‑screen simulated human gut ecosystem with C. difficile ATCC 43599, this study showed that 2′‑FL at 4–8 mg/mL dramatically reduced bacterial growth, prevented toxin production, and reshaped the microbial community—increasing commensals like Blautia while suppressing Clostridium clusters [17].
How to reduce the risk of C. difficile infection
While some risk factors, like antibiotic use or hospital stays. can’t always be avoided, there are simple steps you can take to lower your risk. Supporting your gut microbiome and practising good hygiene are key to helping prevent C. difficile from taking hold.
Practical ways to reduce your risk, include:
- Only use antibiotics when necessary and as prescribed
- Eat a diverse, fibre-rich diet to support gut bacteria
- Support your gut during and after antibiotics
- Wash hands regularly with soap and water
- Be cautious in hospitals and healthcare settings
- Avoid unnecessary use of proton pump inhibitors (PPIs)
- Maintain good overall health (sleep, diet, stress)
- Take extra care if you’ve had C. difficile before
Summary
In summary, C. diff is a bacterium that can cause severe intestinal problems, and antibiotics are a significant risk factor for infection. While antibiotics are often used to treat C. diff infections, there has been growing interest in the use of FMT as an alternative treatment. However, there are concerns about the potential risk of infectious disease transmission and the lack of standardized protocols for FMT. As research in this area continues, it is likely that the controversy surrounding FMT will continue as well.
Support your gut—proactively
If you’re looking to go a step further, targeted prebiotics like human milk oligosaccharides (HMOs) are designed to selectively feed beneficial gut bacteria and support microbiome resilience, especially during or after antibiotic use.
Adding a science-backed prebiotic such as Layer Origin’s PureHMO® to your routine may help support a stronger, more balanced gut environment.
Author details
Written by: Layer Origin
Reviewed by: Leanne Edermaniger, M.Sc. Leanne is a professional science writer who specializes in human health and enjoys writing about all things related to the gut microbiome. She has written extensively on inflammatory bowel disease, prebiotics, and microbiome research.
Her work focuses on translating complex medical science into evidence-based, practical health guidance.
Last updated: March 2026
